Cassidy James 4
4 · SpringWorks Therapeutics, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Cassidy James
Chief Medical Officer
Transactions
- Award
Common Stock
2023-06-30+5,720→ 52,950 total
Footnotes (1)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on June 30, 2024, another thirty three percent (33%) to vest on June 30, 2025 and the remaining thirty four percent (34%) to vest on June 30, 2026, such that the restricted stock awards are fully vested on June 30, 2026.